Jianjun Xiao

Prognostic impact of circulating monocytes and lymphocyte-to-monocyte ratio on previously untreated metastatic non-small cell lung cancer patients receiving platinum-based doublet

Gui‐Nan Lin, Jiewen Peng, Jianjun Xiao et al. · Medical Oncology · 2014 · 67 citations

Lymphocyte-to-monocyte Ratio, Prognostic Biomarkers, Prognostic Impact +10

Elevated neutrophil‐to‐lymphocyte ratio predicts poor outcome in patients with advanced non‐small‐cell lung cancer receiving first‐line gefitinib or erlotinib treatment

Gui‐Nan Lin, Jiewen Peng, Panpan Liu et al. · Asia-Pacific Journal of Clinical Oncology · 2014 · 51 citations

Increased lymphocyte to monocyte ratio is associated with better prognosis in patients with newly diagnosed metastatic nasopharyngeal carcinoma receiving chemotherapy

Gui‐Nan Lin, Jiewen Peng, Dongying Liu et al. · Tumor Biology · 2014 · 45 citations

Serplulimab, a novel anti-PD-1 antibody, in patients with microsatellite instability-high solid tumours: an open-label, single-arm, multicentre, phase II trial

Shukui Qin, Jin Li, Haijun Zhong et al. · British Journal of Cancer · 2022 · 30 citations · Full text

Prognostic significance of the pre-chemotherapy lymphocyte-to-monocyte ratio in patients with previously untreated metastatic colorectal cancer receiving FOLFOX chemotherapy

Gui-Nan Lin, Panpan Liu, Dongying Liu et al. · Chinese Journal of Cancer · 2016 · 26 citations · Full text